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S U M M A R Y
Background: Previous research has suggested that avian inﬂuenza A H7N9 has a greater potential
pandemic risk than inﬂuenza A H5N1. This research investigated the difference in human clustered and
sporadic cases of H7N9 virus and estimated the relative risk of clustered infections.
Methods: Comparative epidemiology and virology studies were performed among 72 sporadic
conﬁrmed cases, 17 family clusters (FCs) caused by human-to-human transmission, and eight live
bird market clusters (LCs) caused by co-exposure to the poultry environment.
Results: The case fatality of FCs, LCs and sporadic cases (36%, 26%, and 29%, respectively) did not differ
among the three groups (p > 0.05). The average age (36 years, 60 years, and 58 years), co-morbidities
(31%, 60%, and 54%), exposure to birds (72%, 100%, and 83%), and H7N9-positive rate (20%, 64%, and 35%)
in FCs, LCs, and sporadic cases, respectively, differed signiﬁcantly (p < 0.05). These higher risks were
associated with increased mortality. There was no difference between primary and secondary cases in
LCs (p > 0.05). However, exposure to a person with conﬁrmed avian inﬂuenza A H7N9 (primary 12% vs.
secondary 95%), history of visiting a live bird market (100% vs. 59%), multiple exposures (live bird
exposure and human-to-human transmission history) (12% vs. 55%), and median days from onset to
antiviral treatment (6 days vs. 3 days) differed signiﬁcantly between primary and secondary cases in FCs
(p < 0.05). Mild cases were found in 6% of primary cases vs. 32% of secondary cases in FCs (p < 0.05).
Twenty-ﬁve isolates from the three groups showed 99.1–99.9% homology and increased human
adaptation.
Conclusions: There was no statistical difference in the case fatality rate and limited transmission
between FCs and LCs. However, the severity of the primary cases in FCs was much higher than that of the
secondary cases due to the older age and greater underlying disease of the latter patients.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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A novel inﬂuenza A H7N9 virus emerged in China in March
2013 as an unexpected cause of severe human illness.1,2 By January
31, 2016, 721 conﬁrmed cases worldwide, including 285 deaths,
had been reported to the World Health Organization.3 Of these,
97% (701/721) were found in mainland China. The other 3% (20/
721) were imported cases identiﬁed in Hong Kong, Taiwan,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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China.4 The case fatality rate for H7N9 has been reported as 40%
(285/721), which is much lower than that of the H5N1 virus (60%),
but signiﬁcantly higher than that of seasonal inﬂuenza (1%).
Although most of these cases had no epidemiological link, a few
family clusters (FCs) were documented in the provinces of Jiangsu,
Guangdong, Shandong, and Zhejiang.5–8 Qin et al. reported that the
proportion of H7N9 human infections occurring in clusters was 8%
of the total cases, which is much lower than the proportion in the
H5N1 groups (20%).9 Genetic sequencing, glycan array receptor-
binding assays, and ferret studies have shown that the H7N9 virus
exhibits increased binding to mammalian respiratory cells. New
risk assessment tools have also indicated that H7N9 has a greater
potential pandemic risk for further mammalian adaptation with
possible human-to-human transmission compared to H5N1.2
Two types of human cluster have been identiﬁed to date. One is
the FC, which involves subjects who have a genetic relationship
and share the same living space, and is caused by close physical
contact. The other is the live bird market cluster (LC), which is
caused by common exposure to an H7N9-positive environment in
individuals without a blood relative relationship. However, the
epidemiological and virological differences in these two clusters
compared to sporadic cases are unclear.10–13 Based on large
samples of human clusters, the current study investigated the
differences in age, sex distribution, case fatality rate, exposure
history, underlying diseases, and clinical severity, in addition to
hemagglutinin (HA) and neuraminidase (NA) gene mutations. The
aim was to identify factors associated with an increased risk of
human transmission and the epidemic patterns of these clusters.
This information may help control a potential global pandemic of
H7N9.
2. Methods
2.1. Ethics statement
The present study was approved by the Zhejiang Medical Ethics
Committee and the National Health and Family Planning
Commission. Written informed consent was obtained from all
patients and/or their families, as well as from individuals who
participated in the study. The sampling activities and data
collection from human cases were approved by the Medical Ethics
Committee of Zhejiang Province.
2.2. Research objectives
The research objectives were to compare the epidemiology and
virology of human FCs and LCs of infection with avian inﬂuenza A
H7N9 virus in China and to identify the risks related to these
clusters.
2.3. Case deﬁnitions9
In accordance with the Chinese guidelines for the diagnosis and
treatment of humans infected with H7N9 avian inﬂuenza (http://
www.moh.gov.cn/mohwsyjbgs/fkzs/list.shtml), a conﬁrmed H7N9
case was deﬁned as a patient with an inﬂuenza-like illness (ILI) or a
suspected case with respiratory specimens that tested positive for
the H7N9 virus by either (1) the isolation of the H7N9 virus or
positive results by real-time reverse-transcriptase PCR (rRT-PCR)
assay for H7N9, or (2) a four-fold or greater rise in antibody titre for
the H7N9 virus based on testing of an acute serum specimen
(collected 7 days or less after symptom onset) and a convalescent
serum specimen (collected at least 2 weeks later).
A cluster was deﬁned as two or more persons with an onset of
symptoms within the same 14-day period, who were associatedwith a speciﬁc setting, such as a classroom, workplace, household,
extended family, hospital, other residential institution, military
barracks or recreational camp, and live bird markets. When the
cluster was identiﬁed in a household, this was deﬁned as a FC;
when the cluster was found in those patients co-exposed to the
same live bird market in a 14-day period, this was deﬁned as a LC.
An index case is deﬁned as the initial patient in the population
of an epidemiological investigation, or more generally the ﬁrst case
with the condition or syndrome (not necessarily contagious) to be
described in the medical literature, whether or not the patient is
thought to be the ﬁrst person affected. The index case may indicate
the source of the disease, the possible spread, and the reservoir that
holds the disease between outbreaks; this is the ﬁrst patient to
indicate the existence of an outbreak. A secondary case is deﬁned
as the occurrence of a disease due to close contact with a primary
case patient in the 2 weeks after onset of illness in the primary
case. A secondary case is the next stage to the primary case.
A mild case of H7N9 was deﬁned as an individual with a
conﬁrmed H7N9 virus infection who met the respiratory infection
criteria and presented with mild respiratory symptoms and no
complications (such as acute respiratory distress syndrome
(ARDS), multi-organ failure, or hypoxemia) throughout the clinical
course.9
A severe case of H7N9 was deﬁned as an individual with a
conﬁrmed H7N9 virus infection who met any one of the
following criteria: presenting with severe respiratory symptoms
with any complication (including ARDS, shock, multi-organ
failure, or hypoxemia) and requiring hospitalization, intensive
care unit admission, or mechanical ventilation for medical
reasons.9 The objective index is as follows: (1) X-ray showing
lesions in multiple lobes or disease progression > 50% within
48 h; (2) dyspnoea with a respiratory rate > 24 breaths per min;
(3) hypoxemia with oxygen saturation 92% on oxygen at a ﬂow
rate of 3–5 l/min; (4) shock, ARDS, or multiple organ dysfunction
syndrome. Patients with a conﬁrmed H7N9 virus infection are
critically ill and approximately 20% die of ARDS or multi-organ
failure.3
A contact was deﬁned as an individual who (1) did not take
protective measures in the diagnosis and treatment of suspected or
conﬁrmed cases, or took care of the patient; (2) lived together or
was in close contact with a suspected or conﬁrmed case within
14 days of illness onset; or (3) were investigators who had close
contact with an index case but did so without any protective gear.
A blood relative contact was deﬁned as parent–offspring,
siblings, grandparent–grandchild, and uncle/aunt–niece/nephew,
who shared the same living space. A non-blood relative contact
was deﬁned as a spouse, healthcare worker, son/daughter-in-law,
parent-in-law, and other unrelated household member, who
shared the same living space.9
2.4. Study design
2.4.1. Data source
In mainland China, all laboratory-conﬁrmed H7N9 cases are
reported to the Chinese Centre for Disease Control and Prevention
(China CDC) through a national system for reporting notiﬁable
infectious diseases. A total of 17 FCs (ﬁve from Zhejiang Province,
three from Guangdong Province, two each from Shanghai, Hunan
Province, and Shandong Province, and one each from Beijing,
Jiangsu Province, and Guangxi Province) involving 39 conﬁrmed
H7N9 cases, and a total of eight LCs from Zhejiang Province
involving 19 conﬁrmed H7N9 cases were identiﬁed in a total of
454 conﬁrmed cases as of December 2014 and included in this
research (Supplementary Material, Figure S1). In addition,
72 sporadic cases occurring in Zhejiang Province were selected
as a control group.
Figure 1. Cluster pedigree showing eight of the live bird market clusters and 17 of
the family clusters infected with avian inﬂuenza A H7N9 in China from March
2013 to December 2014: (a) 17 family clusters (FCs); (b) eight live bird market
clusters (LCs).
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The epidemiological data of all conﬁrmed cases in Zhejiang
Province used in this study were collected by ﬁeld staff for the
purpose of this study. Under the Chinese avian H7N9 inﬂuenza
surveillance system, once a suspected case is conﬁrmed to be H7N9-
positive, a joint ﬁeld investigation team comprising staff from the
local or provincial level CDC and/or the China CDC conduct ﬁeld
investigations of the laboratory-conﬁrmed cases of H7N9 virus
infection. Demographic, epidemiological, and basic clinical data on
the H7N9 cases are collected using standardized forms. An integrated
database is constructed by the China CDC and Zhejiang CDC. Field
investigators interview the conﬁrmed case(s) and/or their relatives to
determine the exposure history 2 weeks before onset, the source of
the infection, clinical course, and epidemiological information
including occupation, smoking habit, and history of exposure to
birds and symptomatic contacts. In addition, the close contacts are
monitored daily for 14 days for symptoms of illness. All available
medical records were provided by local clinical healthcare workers.
2.5. Laboratory conﬁrmation
Speciﬁc RT-PCR assays for seasonal inﬂuenza viruses (H1, H3,
and B) and avian inﬂuenza (H5N1 and H7N9) were performed as
described previously.14 All specimens positive for viral RNA were
inoculated into Madin–Darby canine kidney (MDCK) cell cultures
for viral isolation. Viral genetic sequences were obtained directly
from clinical specimens or from virus isolates, using an Illumina
MiSeq Personal Sequencer, as described by Gao R et al. previously.1
2.6. Statistical analyses
All statistical analyses were conducted using SAS 9.2 (SAS
Institute, Cary, NC, USA). Analysis of variance (F-test) was applied
to the measurement data. Chi-square tests were applied to
compare the distribution of the different variables of qualitative
measurements among the three groups. All p-values were two-
sided and subject to a local signiﬁcance level of 0.05.
3. Results
3.1. Epidemiological comparison among FCs, LCs, and sporadic cases
A total of 25 clusters (58 conﬁrmed cases) were included, of which
17 were FCs (involving 39 cases) reported across China from March
2013 to December 2014 and eight were LCs (involving 19 cases)
reported in Zhejiang Province (Figure 1); 72 sporadic cases were
selected in Zhejiang Province as the control group. The percentage of
cluster cases to total cases was 9% (39/454) for FCs and 4% (19/454) for
LCs, and the cluster size ranged from two in the LCs to four in the FCs
(Figure 1; Supplementary Material, Figure S1, Table S1).
The mean age in the FCs was 36 years (range 1–87 years), in the
LCs was 60 years (range 32–86 years), and in the sporadic group
(controls) was 58 years (range 5–84 years) (p > 0.05) (Figure 2a–c).
Signiﬁcant differences were found in occupation, smoking habits,
comorbidities, exposure history, and the percentage of symptom-
atic contacts among the three groups (p < 0.05) (Table 1).
3.2. Epidemiological comparison between the primary and secondary
cases
Twenty-ﬁve index cases were identiﬁed, with 17 primary cases
from FCs and eight primary cases from LCs. A total of 33 secondary
cases were also found, including 22 from FCs and 11 from LCs. In
the LCs groups, the mean age of the eight primary cases was
64 years (range 40–84 years) and of the 11 secondary cases was
58 years (range 32–86 years) (p > 0.05, difference not signiﬁcant).In contrast, there was a signiﬁcant difference in mean age between
the 17 primary cases (39 years, range 1–61 years) and the
22 secondary cases (34 years, range 2–87 years) in the FCs group
(p < 0.05) (Figure 2d, e).
Figure 2. Age distribution among 17 family clusters (including 17 primary cases and 22 secondary cases), eight live bird market clusters (including eight primary cases and
11 secondary cases), and 72 sporadic cases infected with avian inﬂuenza A H7N9 in China from March 2013 to December 2014: (a) total family cluster cases; (b) total live bird
market cluster cases; (c) total sporadic cases; (d) primary and secondary cases from the family clusters (light yellow denotes primary cases and dark yellow denotes
secondary cases); (e) primary and secondary cases from live bird market clusters (light blue denotes primary cases and dark blue denotes secondary cases).
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Table 1
Comparison of 17 family clusters (39 cases), eight live market clusters (19 cases), and 72 sporadic cases with avian inﬂuenza A H7N9 virus in China
Epidemiological characteristics Family cluster
cases (n = 39)
Live bird market
cluster cases
(n = 19)
Sporadic cases
(n = 72)
F-value/Chi-square
value
p-Value
Number of clusters 17 8 0
Percentage of cluster cases in total cases, n (%) 39/454 (9) 19/454 (4) -
Size of cluster, n 2–4 2–5 1
Source area, n (%) 2.102 0.350
Urban 6 (35) 3 (38) 38 (53)
Rural 11 (65) 5 (63) 34 (47)
Age, years, mean (range)a 36 (1–87) 60 (32–86) 58 (5–84) 20.099 0.000
Sex, n (%) 1.64 0.440
Male 22 (56) 13 (68) 49 (68)
Female 17 (44) 6 (32) 23 (32)
Occupation, n (%)a 27.08 0.000
Farmer 10 (26) 4 (21) 34 (47)
Retired worker 9 (23) 7 (74) 14 (19)
Preschool/school 11 (28) 0 (0) 1 (1)
Other 9 (23) 8 (42) 23 (32)
High risks, n (%)
Smokinga 3 (8) 2 (11) 5 (7) 260 0.000
Alcohol drinking 4 (10) 2 (11) 1 (1) 5.059 0.08
Chronic comorbidities, n (%) 16 (41) 10 (53) 35 (49) 3.579 0.466
One comorbidity 11 (69) 4 (40) 16 (46)
Two or more comorbidities 5 (31) 6 (60) 19 (54)
Chronic lung disease (COPD, TB, asthma)a 1 (6) 3 (30) 1 (3) 8.677 0.013
Chronic cardiac disease (hypertension, coronary disease)a 3 (19) 8 (80) 26 (74) 12.07 0.002
Metabolic disease (diabetes, hyperthyroidism) 3 (19) 2 (2) 14 (40) 3.098 0.212
Chronic immunosuppressive disordera 8 (50) 2 (20) 2 (6) 9.541 0.008
Other 2 (13) 6 (60) 7 (20) 9.279 0.010
Chronic drug history, n (%) 7 (18) 6 (32) 13 (18) 1.865 0.394
History of exposure to birds, n (%)a 28 (72) 19 (100) 60 (83) 7.096 0.029
Contacts, n (%) 272 253 717
Symptomatic contactsa 7 (3) 14 (6) 6 (1) 34.85 0.000
Contacts with RNA positive 5 (2) 0 (0) 0 (0)
Case fatality rate, n (%) 14 (36) 5 (26) 21 (29) 0.745 0.689
COPD, chronic obstructive pulmonary disease; TB, tuberculosis. Analysis of variance (F-test) was applied to weigh the quantity data statistically. Fisher’s exact test was used in
the analysis of contingency tables when the sample sizes were small. The Chi-square test was applied to compare the distribution of the different variables of qualitative
measurements.
a The difference between the two groups was signiﬁcant (p < 0.05).
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relationship was found in 1.8:1 vs. 0:19 in FCs and LCs, respectively
(p < 0.05). The median number of days from onset of the primary
case to onset of the secondary case was 9 days for FCs and 5 days for
LCs (Table 2).
3.3. Comparison of exposure history among LCs, FCs, and sporadic
cases
Analysis of the infection source indicated that 100% (8/8) of LCs
were caused by co-exposure to live bird markets. In contrast, a
small fraction (6%, 1/17) of FCs were caused by co-exposure to live
bird markets only, whereas 88% (15/17) were caused by person-to-
person transmission (i.e., secondary cases had contact with
primary cases, such as through bedside care or sharing a bedroom)
and 29% (5/17) were caused by both. The difference between the
two groups was signiﬁcant (p < 0.05) (Supplementary Material,
Table S2). Collectively, there was an obvious difference in the type
of exposure to poultry, exposure frequency, and the H7N9-positive
rate for those exposed to live bird markets among the three groups
(Table 2).
3.4. Clinical comparison among LCs, FCs, and sporadic cases
No statistical difference was identiﬁed in the clinical period from
onset to outcome (death or discharge), except for the median period
from onset to hospitalization, which was 3 days for the FCs, 4 days for
the LCs, and 5 days for sporadic cases (p < 0.05) (Figure 3a).There was no statistical difference between the primary and
secondary LC cases for the clinical period. There was also no
difference between the primary and secondary FC cases except for
the median period from onset to antiviral treatment (6 and 3 days,
respectively; p < 0.05) (Figure 3b).
The clinical spectrum for the LC, FC, and sporadic cases groups
were as follows: asymptomatic for 0% (0/19), 3% (1/35), and 0% (0/
72), respectively; mild for 0% (0/19), 26% (9/35), and 1% (1/72);
severe for 74% (14/19), 37% (13/35), and 69% (50/72); and fatal
(death) for 26% (5/19), 34% (12/35), and 29% (21/72) (Figure 4a).
There were no asymptomatic or mild cases in the primary and
secondary cases of the LCs. Severe cases accounted for 75% (6/8)
and 73% (8/11) and fatal cases (death) for 25% (2/8) and 27% (3/11)
in the primary and secondary cases, respectively (p > 0.05)
(Figure 4b, Table 2).
For the FCs, primary cases were mild (6%, 1/17), severe (35%, 6/
17), and fatal (death 47%, 8/17), while secondary cases were
asymptomatic (5%, 1/22), mild (32%, 7/22), severe (36%, 8/22), and
fatal (death 27%, 6/22) (Figure 4b, Table 2).
3.5. Molecular evolution and mutation among LCs, FCs, and sporadic
cases
Whole genome sequencing was performed for 25 representative
isolates from the FCs (n = 13), LCs (n = 3), and sporadic cases (n = 9).
Alignment of the generated sequences showed 99.1–99.9%
homology at the eight genetic segments of all isolates. The
clustering pattern at the HA and NA tree showed that all isolates
Table 2
Comparative epidemiology of primary cases and secondary cases among 17 family cluster and eight live market cluster cases infected with H7N9 avian inﬂuenza in China
during 2013 to 2014.
Epidemiological characteristics Family clusters (n = 39) Live bird market cluster (n = 19)
Primary cases
(n = 17)
Secondary
cases
(n = 22)
p-Value Primary cases
(n = 8)
Secondary
cases
(n = 11)
p-Value
Total cases 17 22 8 11
Age, years, mean (range) 39 (1–61) 34 (2–87) 0.524 64 (40–84) 58 (32–86) 0.472
Male to female ratio 3.3:1 1:1.4 0.109 1:1 2.7:1 0.541
Occupation, n (%)
Farmer 6 (35) 4 (18) 0.282 2 (25) 2 (18) 1.000
Retired worker 5 (29) 4 (18) 0.465 3 (38) 4 (36) 1.000
Preschool/school 4 (23) 7 (32) 0.725 0 (0) 0 (0) 1.000
Other 2 (12) 7 (32) 0.251 3 (38) 3 (27) 1.000
Exposure history, n (%) 17 (100) 22 (100) 0.725 8 (100) 11 (100) 1.000
Febrile casesa 2 (12) 21 (95) 0.000 0 (0) 0 (0) 1.000
Live bird market/birdsa 17 (100) 13 (59) 0.002 8 (100) 11 (100) 1.000
Multiple exposuresa 2 (12) 12 (55) 0.008 0 (0) 0 (0) 1.000
Clinical period, median days
From exposure to onset 2 3 0.433 2 2.5 0.884
From onset to consultation 1 1 0.260 1 1 0.626
From onset to conﬁrmation 8 5 0.845 7.5 6.0 0.170
From onset to admission 3 3 0.983 3.5 4.0 0.307
From onset to outcome 17 13 0.550 19 21 0.319
From onset to antiviral treatmenta 6 3 0.004 4 4 1.000
Be hospitalized 10.5 14 0.241 19 18 0.448
Comorbidity, n (%) 7 (41) 7 (32) 1.000 5 (63) 4 (36) 0.370
Clinical severity, n (%)
Asymptomatic 0 (0) 1 (5) 1.000 0 (0) 0 (0)
Mild 1 (6) 7 (32) 0.106 0 (0) 0 (0)
Severe 6 (35) 8 (36) 1.000 6 (75) 8 (73) 1.000
Fatal (death) 8 (47) 6 (27) 0.314 2 (25) 3 (27) 1.000
Unknown 2 (12) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Genetic relationship to non-genetic relationship ratio 1.8:1 0:19
Onset from primary case to secondary cases, days 9 5
The Chi-square test was applied to compare the distribution of the different variables of qualitative measurements.
a The difference between the two groups was signiﬁcant (p < 0.05).
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to vaccine strains (A/Anhui/1/2013/H7N9).
For the HA gene, R47K was found in 0/3 isolates from the LCs, 8/
13 isolates from the FCs, and 3/9 isolates from the sporadic cases.
R47 M was only identiﬁed in 2/9 sporadic cases and K141R was
only detected in one of the isolates from the LCs (A/Zhejiang/8/
2013_H7N9). Most of the HA sequences were ‘G’ at amino acid
position 228 and ‘L’ at amino acid position 226. R304G was found in
only one isolate from the LCs (A/Huzhou/5/2013_H7N9 S LBM)
(Supplementary Material, Figure S2a).
NA sequence analyses showed that E120 was identiﬁed in all of
the NA sequences but in only one of the FC isolates (A/Jiangsu/02/
2013_H7N9), with E120 V. R294K was found in only one isolate
from the sporadic cases (A/Zhejiang/LS01/2014_H7N9) and two
from the FCs (A/Shanghai/CN01/2013_H7N9 and A/Shanghai/1/
2013_H7N9) (Supplementary Material, Figure S2b).
Q591K substitutions were not found in the polymerase basic 2
(PB2) segments of the three groups, but were found in one sporadic
case (A/Zhejiang/DTID-ZJU08/2013). The E627K mutation was
found in 0/3 LC cases, 8/9 FC cases, and 6/9 sporadic cases. D701N
was identiﬁed in 3/9 sporadic cases (Supplementary Material,
Table S3).
4. Discussion
A difference in the circulating pattern of LCs and FCs was found.
All occurrences of LCs were identiﬁed among non-family members
in Zhejiang Province, in which a third of severe cases in China have
been reported. LCs were found in genetically unrelated persons
with a common exposure to the same markets within 2 weeksof onset. These ﬁndings are in contrast to those of the FCs for
H7N9 and H5N1, in which 90% of cases occurred in blood
relatives, especially in those with a ﬁrst-degree relationship,
suggesting a genetic basis for susceptibility to avian inﬂuenza
virus infection.15,16
The epidemiological investigation indicated that the average
age of those in the LCs was older than that of the H7N9 FC subjects
and older than that of the H5N1 FC subjects. However, no obvious
difference was found in the sex distribution among LCs and FCs.
Three main reasons may explain the age distribution: (1) age-
associated practices and norms; (2) biological differences between
different ages; and (3) differential healthcare-seeking/access
behaviour between the different groups.17 Although 60% of LC
subjects had two or more underlying diseases, only 31% of FC
subjects were similarly afﬂicted.18 The older population may
become infected with H7N9 more easily because of the age-related
decline in physical capacity and performance and especially in the
immune system.
There were no obvious differences in mortality, source area,
alcohol consumption, or positive contacts. In agreement with
previous reports, the outbreak size of the two cluster types did not
differ and involved two to ﬁve members; this also indicates that
the reproduction number for human-to-human transmission is
well below 1. Disease transmission is very similar to that of H5N1
but less than that of seasonal H1N1 inﬂuenza.19 The present study
ﬁndings also support the notion that the virus still has a limited
and non-sustained transmission capability. In general, the older
population with a non-genetic relationship, especially with severe
basic conditions, was predominant in the LC population, but
transmission was very limited among LCs as well as FCs.18
Figure 3. Median days from illness onset to outcome among 17 family clusters (including 17 primary cases and 22 secondary cases), eight live bird markets clusters (including
eight primary cases and 11 secondary cases), and 72 sporadic cases infected with avian inﬂuenza A H7N9 in China from March 2013 to December 2014. (a) Total cluster cases
(red denotes family cluster, blue denotes live bird market cluster, and green denotes sporadic cases): from exposure to onset F = 0.442, p = 0.645; from onset to consultation
F = 0.026, p = 0.974; from onset to conﬁrmation F = 1.008, p = 0.368; from onset to admission F = 3.346, p = 0.039; from onset to antiviral treatment F = 0.643, p = 0.529;
hospitalized days F = 0.910, p = 0.406; from onset to outcome F = 1.448, p = 0.242. (b) Primary and secondary cases (for family clusters, light yellow denotes primary cases and
dark yellow denotes secondary cases; for live bird market clusters, light blue denotes primary cases and dark blue denotes secondary cases); days from onset to antiviral
treatment, p = 0.004.
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birds, which raises questions regarding the source and transmis-
sion route of the inﬂuenza A H7N9 virus and supports the
hypothesis of aerosol transmission.20 A high frequency, high dose,
and repeated co-exposure/contact with highly polluted live bird
markets led to a high risk for the LCs group. These results implicate
wet markets as a causative link with human H7N9 infection.21
In terms of primary and secondary cases in the LCs, there was no
obvious difference in age, sex, occupation, exposure history and
median days, basic diseases, or clinical spectrum. However, in the
FCs group, primary cases were infected through the live bird
market, while secondary cases were generally due to person-to-
person transmission.22 The mean incubation period from the
primary to secondary cases in the FCs (9 days) was signiﬁcantly
longer than that for the LCs and other reported sporadic cases
(3 days);23 however, it was signiﬁcantly shorter than that of H5N1
FCs (14 days). This may be attributed to exposure frequency, dose,
and types, as well as with age, sex, susceptibility, and the immune
level of the secondary case.
The analysis of clinical features showed a statistical difference
in the median days from onset to hospital admission in three
groups; this may have been due to delayed consultation being
related to illness severity.23 Additionally, the average number of
days from onset to antiviral treatment in the primary cases of the
FCs was greater than that of the secondary cases. This could be
attributed to the fact that secondary cases, as close contacts, were
under investigation by local public health doctors, which
facilitated early diagnosis and the start of antiviral treatment
once the patient had developed clinical symptoms.24 Interestingly,
most of the FC primary cases experienced severe and fatalmanifestations, which is in contrast to the secondary cases, who
showed mild conditions. This differs from the H5N1 FCs, in which
secondary cases were severe and fatal.25 Furthermore, this result is
in agreement with those stated previously based on clinical and
epidemiological data.26,27
In agreement with previous studies, sequence analysis of
representative isolates from the different groups showed 99.1–
99.9% homology at the eight genomic segments and phylogenetic
clustering with other Chinese isolates that have been characterized
as remaining antigenically similar to the candidate vaccine virus
derived from A/Anhui/1/2013-like viruses.27 In this study, the
substitution of Q226L and G228 of HA was found in all LCs and FCs,
indicating that the virus shares a high afﬁnity and adaptability to
humans. The avian inﬂuenza H7N9 virus has also shown increased
transmissibility in experimentally infected ferrets compared to the
H5N1 virus.28–31 Most of the FC cases presented with R56K
(antigenic E sites) and R312K (antibody binding sites). The role of
these substitutions at positions 56 and 312 (H3 numbering) in the
HA segment is not well established, but this merits further study.
Only three of the isolates had a mutation in the NA gene (R294K) in
the three groups; this mutation confers a lack of resistance to
oseltamivir and peramivir.32 The PB2 gene encodes proteins that
compose the polymerase enzyme complex, which is necessary for
viral replication.33,34 This amino acid change has been shown to
increase virulence in a mouse model, increase transmission in a
ferret model, and enhance virus replication efﬁciency in a pig
model.35–37 The PB2 proteins isolated from FCs had mutations at
position E627K, which leads to enhanced replication in the airway
of mammalian hosts and possibly humans.1,38,39 In contrast, PB2
from H7N9 viruses isolated from LCs retained ‘E’ at position 627,
Figure 4. Clinical spectrum among 17 family clusters (including 17 primary cases and 22 secondary cases), eight live bird market clusters (including eight primary cases and
11 secondary cases), and 72 sporadic cases infected with avian inﬂuenza A H7N9 in China from March 2013 to December 2014: (a) total clustered cases (red denotes deaths,
blue denotes severe cases, yellow denotes mild cases, and purple denotes asymptomatic cases); (b) primary and secondary cases in family clusters and live bird market
clusters (red denotes deaths, blue denotes severe cases, yellow denotes mild cases, and purple denotes asymptomatic cases).
Z. Wu et al. / International Journal of Infectious Diseases 49 (2016) 9–1716suggesting that the mutation is positively selected from an avian
origin. Another substitution (D701N) in PB2 was found in some
sporadic cases but not in cluster cases; this likely contributes to the
increased disease seen in humans with H7N9 infection but does
not seem to increase human-to-human transmission.
In conclusion, the ﬁndings of the present study showed that the
case fatality rate was similar in the FC and LC groups compared to
the sporadic cases with avian inﬂuenza H7N9 virus. Although the
FC and LC cases were caused by human-to-human exposure and
co-exposure to the poultry environment, respectively, there was
no difference in the extent of transmission. However, the severity
of disease in the primary cases in the FCs was much greater than
that in the secondary cases due to the older age, more severe
underlying diseases, and delayed antiviral treatment in these latter
cases.
In the future, the virus will likely continue to circulate in live
bird markets, animals, and humans, with the potential to spread
beyond China. It is essential to take effective measures to control
the source of infection, improve viral surveillance, and strengthen
medical observations of close contacts.
Acknowledgements
The authors thank all of the staff at the Prefecture CDC for their
great help in the ﬁeld investigation and collection of environmen-
tal samples. We are grateful to Dr Mark Thompson from the
Centers for Disease Control and Prevention, Atlanta, GA, USA, for
proofreading the manuscript.Conﬂict of interest: The authors declare that no competing
interests exist in relation to the present study. Each author
approved the ﬁnal manuscript.
Funding: This work was supported by a grant from the
Provincial Medical Research Fund of Zhejiang, China (grant
number 2013KYA043), a Key Program grant from the Science
Technology Department of Zhejiang Province in China (grant
number 2014C03039), an epidemiology supporting grant
from Zhejiang Provincial Health and the Family Planning
Commission of the Shanghai Municipal Commission of Science
and Technology Program (grant number 14495810301), and a
grant from the Anhui Province of International Science
and Technology Cooperation Program (grant number
1503062008).
Author contributions: Shelan Liu and Zuqun Wu had full access
to all the data in the study and drafted the manuscript. Zhao Yu,
Wei Cheng, and Jianping Sha were responsible for the study
concept and design. Na Zhao and Ta-Chien Chan were responsible
for the analysis and interpretation of the data. Said Amer and
Zhiruo Zhang performed the statistical analysis.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.ijid.
2016.05.022.
Z. Wu et al. / International Journal of Infectious Diseases 49 (2016) 9–17 17References
1. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel
avian-origin inﬂuenza A (H7N9) virus. N Engl J Med 2013;368:1888–97.
2. Liu S, Sha J, Yu Z, Hu Y, Chan TC, Wang X, et al. Avian inﬂuenza virus in
pregnancy. Rev Med virol 2016. http://dx.doi.org/10.1002/rmv.1884 [Epub
ahead of print].
3. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, et al. Epidemiology of human infections
with avian inﬂuenza A(H7N9) virus in China. N Engl J Med 2014;370:520–32.
4. Yu H, Cowling BJ, Feng L, Lau EH, Liao Q, Tsang TK, et al. Human infection with
avian inﬂuenza A H7N9 virus: an assessment of clinical severity. Lancet
2013;382:138–45.
5. Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, Tang FY, et al. Probable person to person
transmission of novel avian inﬂuenza A (H7N9) virus in Eastern China, 2013:
epidemiological investigation. BMJ 2013;347:f4752.
6. Jie Z, Xie J, He Z, Song Y, Hu Y, Li F, et al. Family outbreak of severe pneumonia
induced by H7N9 infection. Am J Respir Crit Care Med 2013;188:114–5.
7. Rudge JW, Coker R:. Human to human transmission of H7N9. BMJ 2013;347:
f4730.
8. Yi L, Guan D, Kang M, Wu J, Zeng X, Lu J, et al. Family clusters of avian inﬂuenza A
H7N9 infection in Guangdong Province, China. J Clin Microbiol 2014;53(1):22–8.
9. Qin Y, Horby PW, Tsang TK, Chen E, Gao L, Ou J, et al. Differences in the
epidemiology of human cases of avian inﬂuenza A(H7N9) and A(H5N1) viruses
infection. Clin Infect Dis 2015;61:563–71.
10. Li J, Yu X, Pu X, Xie L, Sun Y, Xiao H, et al. Environmental connections of novel
avian-origin H7N9 inﬂuenza virus infection and virus adaptation to the human.
Science China Life Sciences 2013;56:485–92.
11. Cui L, Liu D, Shi W, Pan J, Qi X, Li X, et al. Dynamic reassortments and genetic
heterogeneity of the human-infecting inﬂuenza A (H7N9) virus. Nat Commun
2014;5:3142.
12. Bao CJ, Cui LB, Zhou MH, Hong L, Gao GF, Wang H. Live-animal markets and
inﬂuenza A (H7N9) virus infection. N Engl J Med 2013;368:2337–9.
13. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, et al. Pathogen-
esis and transmission of avian inﬂuenza A (H7N9) virus in ferrets and mice.
Nature 2013;501:556–9.
14. Liu S, Sun J, Cai J, Miao Z, Lu M, Qin S, et al. Epidemiological, clinical and viral
characteristics of fatal cases of human avian inﬂuenza A (H7N9) virus in
Zhejiang Province, China. J Infect 2013;67:595–605.
15. Aditama TY, Samaan G, Kusriastuti R, Purba WH, Misriyah, Santoso H, et al. Risk
factors for cluster outbreaks of avian inﬂuenza A H5N1 infection, Indonesia. Clin
Infect Dis 2011;53:1237–44.
16. Xiao XC, Li KB, Chen ZQ, Di B, Yang ZC, Yuan J, et al. Transmission of avian
inﬂuenza A(H7N9) virus from father to child: a report of limited person-to-
person transmission, Guangzhou, China, January 2014. Euro Surveill 2014;19(25):
1–9.
17. Arima Y, Vong S, World Health Organization Outbreak Response Team. Human
infections with avian inﬂuenza A(H7N9) virus in China: preliminary assessments
of the age and sex distribution. Western Pac Surveill Response J 2013;4:1–3.
18. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical ﬁndings in 111 cases
of inﬂuenza A (H7N9) virus infection. N Engl J Med 2013;368:2277–85.
19. Nishiura H, Mizumoto K, Ejima K. How to interpret the transmissibility of novel
inﬂuenza A(H7N9): an analysis of initial epidemiological data of human cases
from China. Theor Biol Med Model 2013;10:30.
20. Xu L, Bao L, Deng W, Dong L, Zhu H, Chen T, et al. Novel avian-origin human
inﬂuenza A(H7N9) can be transmitted between ferrets via respiratory droplets.
J Infect Dis 2014;209:551–6.21. Yu H, Wu JT, Cowling BJ, Liao Q, Fang VJ, Zhou S, et al. Effect of closure of live
poultry markets on poultry-to-person transmission of avian inﬂuenza A H7N9
virus: an ecological study. Lancet 2014;383:541–8.
22. Liu Q, He B, Huang SY, Wei F, Zhu XQ. Severe fever with thrombocytopenia
syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis 2014;14:763–72.
23. Cowling BJ, Jin L, Lau EH, Liao Q, Wu P, Jiang H, et al. Comparative epidemiology
of human infections with avian inﬂuenza A H7N9 and H5N1 viruses in China: a
population-based study of laboratory-conﬁrmed cases. Lancet 2013;382:
129–37.
24. Qiu C, Yuan S, Tian D, Yang Y, Zhang A, Chen Q, et al. Epidemiologic report and
serologic ﬁndings for household contacts of three cases of inﬂuenza A (H7N9)
virus infection. J Clin Virol 2014;59:129–31.
25. Shi J, Xie J, He Z, Hu Y, He Y, Huang Q, et al. A detailed epidemiological and
clinical description of 6 human cases of avian-origin inﬂuenza A (H7N9) virus
infection in Shanghai. PLoS One 2013;8:e77651.
26. Ip DK, Liao Q, Wu P, Gao Z, Cao B, Feng L, et al. Detection of mild to moderate
inﬂuenza A/H7N9 infection by China’s national sentinel surveillance system for
inﬂuenza-like illness: case series. BMJ 2013;346:f3693.
27. Wang D, Yang L, Gao R, Zhang X, Tan Y, Wu A, et al. Genetic tuning of the novel
avian inﬂuenza A(H7N9) virus during interspecies transmission, China, 2013.
Euro Surveill 2014;19(25):1–13.
28. Yamayoshi S, Yamada S, Fukuyama S, Murakami S, Zhao D, Uraki R, et al.
Virulence-affecting amino acid changes in the PA protein of H7N9 inﬂuenza A
viruses. J Virol 2014;88:3127–34.
29. Zhang H, Li X, Guo J, Li L, Chang C, Li Y, et al. The PB2 E627K mutation
contributes to the high polymerase activity and enhanced replication of
H7N9 inﬂuenza virus. J Gen Virol 2014;95(Pt 4):779–86.
30. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, et al. Origin and diversity of novel
avian inﬂuenza A H7N9 viruses causing human infection: phylogenetic, struc-
tural, and coalescent analyses. Lancet 2013;381:1926–32.
31. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, et al. Genetic
analysis of novel avian A(H7N9) inﬂuenza viruses isolated from patients in
China, February to April 2013. Euro Surveill 2013;18:20453.
32. Jernigan DB, Cox NJ. H7N9: preparing for the unexpected in inﬂuenza. Annu Rev
Med 2015;66:361–71.
33. Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, et al.
Inﬂuenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss
of in vivo virulence or transmissibility. Nat Commun 2013;4:2854.
34. Sleeman K, Guo Z, Barnes J, Shaw M, Stevens J, Gubareva LV. R292K substitution
and drug susceptibility of inﬂuenza A(H7N9) viruses. Emerg Infect Dis 2013;19:
1521–4.
35. Li Z, Chen H, Jiao P, Deng G, Tian G, Li Y, et al. Molecular basis of replication of
duck H5N1 inﬂuenza viruses in a mammalian mouse model. J Virol 2005;79:
12058–64.
36. Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, Li Z, et al. Identiﬁcation of amino acids
in HA and PB2 critical for the transmission of H5N1 avian inﬂuenza viruses in a
mammalian host. PLoS Pathog 2009;5:e1000709.
37. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, et al. Human infections with the
emerging avian inﬂuenza A H7N9 virus from wet market poultry: clinical
analysis and characterisation of viral genome. Lancet 2013;381:1916–25.
38. Dai J, Zhou X, Dong D, Liu Y, Gu Q, Zhu B, et al. Human infection with a novel
avian-origin inﬂuenza A (H7N9) virus: serial chest radiographic and CT ﬁnd-
ings. Chinese Medical Journal 2014;127:2206–11.
39. de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, Kuiken T, et al.
Molecular determinants of adaptation of highly pathogenic avian inﬂuenza
H7N7 viruses to efﬁcient replication in the human host. J Virol 2010;84:
1597–606.
